EligibleTrials

Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)

Recruiting · NCT06427460 · Interventional (participants receive a specific treatment) · Lead sponsor: Changhai Hospital

View the official record on ClinicalTrials.gov →
Pancreatic Cancer

Interventions studied

Central-boost ablative dose delivered by stereotactic body radiation therapy

What this trial is about

In the case of large tumors or tumors closely adjacent to organs at risk, ablative doses offered by stereotactic body radiation therapy (SBRT) could not be delivered. Therefore, a technique that could provide high radiation doses to tumors without increasing of risks of severe adverse effects is required.

Who can take part

Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.